Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer

NCT03207139 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT03207139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 22, 2017
Completion date
June 30, 2019
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

latent cancer prostate